Presence of the t(2;5) in Hodgkin's Disease

To the Editor:
Weiss et al' investigated the translocation t(2:S) in Hodgkin's disease (HD), a translocation primarily thought to be specitic for anaplastic large cell lymphoma, CD30'. They tested 34 cases and were not able to detect t(2;S) in a single case. This is in sharp contrast to the results we described recently. ' We were able to demonstrate t(2:S) in about 70% to 80% of cases of HD. These discrepancies may be most probably caused by technical factors and different methods used. The following considerations seem thus to be important:
( I ) Although we used fresh-frozen material, Weiss et al used formalin-fixed and paraffin embedded tissue, for which it was shown earlier that most RNA molecules (>90%) are crosslinked or degraded and therefore not available for cDNA synthesis and subsequent PCR amplification.' These observations correspond well with our studies on the influence of formalin fixation and subsequent RNA-analysis by reverse transcriptasepolymerase chain reaction (RT-PCR) (unpublished data. May 1995). where less than 10% of the RNA obtained from fresh material was recovered from formalin-fixed tissue. Moreover. RNA from formalin-fixed tissue was an inefficient template generating hardly less than 11100, if any amplitication product at all compared with that of fresh material. (2) Even if it might be possible to amplify house-keeping genes, eg. P-actin, &globin, or highly expressed genes like npm. which are amplifiable from every cell, it does not mean that lower expressed genes are detectable. For personal use only. on October 23, 2017. by guest www.bloodjournal.org From 175-bp product; however, as discussed earlier, the primers they used for npdalk amplification are not optimal.'l They may allow amplification of npdalk when abundant transcripts are available as in cases of anaplastic large cell lymphoma (ALCL), where almost every cell should be positive, but they may fail for lower gene expression as it has to be expected in HD.
Furthermore, the investigators mentioned mixing experiments, which should hold a sensitivity of I in IO6 cells, but ;5) . This can best be compared with the rearrangement studies of T-cell receptor or IgH chain genes in HD which is also found only in a small number of cases by Southem analysis because of the low sensitivity of this latter method.
In our report we have speculated on the number of t Response Drs Orsheschek and colleagues raise a number of theoretical concerns about the validity of our negative findings. We still believe our work to be valid, despite their concerns. Although there is no doubt that there may he degradation of RNA in formalin-fixed, paraffin-embedded tissues, previous studies have shown that RNA may still be easily amplified.' We believe our own sensitivity studies also address this issue. Our positive control cell line was made into a cell pellet, fixed in formalin, and embedded in paraffin to simulate our specimens as closely as possible. Our polymerase chain reaction (PCR) studies were positive to I in IO" cells, which should be adequate to detect expression in Reed-Stemberg cells, which comprise approximately I % of tumor tissue. Of course, we cannot completely rule out the possibility that the expression of the alWnpm transcript in Reed-Stemberg cells is several orders of magnitude lower than our control cell line; however, we believe this is an unlikely possibility. Similarly, we agree with Orsheschek that there is no perfect control to ensure amplifiable RNA in the tissue. Nonetheless, we chose one, the normal npm reverse transcriptase-PCR product, which we thought most closely approximated detection of the alkhpm product. Since there is about a 1,000-bp intron between the primers (M. Raffeld, unpublished data), the product we detected at 185 bp should reflect only mRNA and not DNA.
We believe that the burden of proof of results lies with Dr Orscheschek and colleagues. Their demonstration of t(2;S) in 70% to 80% of cases of Hodgkin's disease has not been confirmed by multiple studies of large numbers using a variety of tissues (including freshfrozen tissues) using a variety of techniques, with 152 cases studied by reverse transcriptase-PCR.'" including over 63 cases studied with fresh frozen tissue".'; 77 cases studied by in situ hybridization'; and I 14 cases studied immunohi~tochemistry~~'~~; totalling 244 negative cases without one positive. Of course, these results do not rule out the possibility that rare cases of Hodgkin's disease, such as Orscheschek and colleagues report above, may truly possess the t(2:S). However, it is well known that false-positive results due to 
